Belluscura (LSE:BELL) OCF Yield %: 0.00 (As of Jun. 29, 2026)


What is Belluscura OCF Yield %?

Belluscura LSE:BELL OCF Yield % is 0.00 as of Jun. 29, 2026.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Belluscura's Trailing 12-Month Cash Flow from Operations is £-7.65 Mil, and Market Cap is £3.01 Mil. Therefore, Belluscura's OCF Yield % for today is 0.00%.

The historical rank and industry rank for Belluscura's OCF Yield % or its related term are showing as below:


LSE:BELL's OCF Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.76
* Ranked among companies with meaningful OCF Yield % only.

Belluscura's OCF Margin % for the quarter that ended in Jun. 2024 was %.

Belluscura OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Belluscura OCF Yield % Related Terms

Belluscura OCF Yield % Historical Data

* Premium members only.

The historical data trend for Belluscura's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Belluscura OCF Yield % Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
OCF Yield %
Get a 7-Day Free Trial 0.00 0.00 -4.12 -15.19 -22.81

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -14.32 -11.54 -17.30 -21.19 -33.86

Belluscura OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Belluscura's OCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-7.214 / 31.63259
=-22.81%

Belluscura's annualized OCF Yield % for the quarter that ended in Jun. 2024 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-4.299 * 2 / 25.3936
=-33.86%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
Belluscura (LSE:BELL) has a OCF Yield % of 0.00 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Belluscura and its competitors.
Is Belluscura's OCF Yield % too high?
Belluscura's current OCF Yield % is 0.00.
How does Belluscura's OCF Yield % compare to ABT and BSX?
Belluscura's OCF Yield % of 0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median OCF Yield % is 1.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.76, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Belluscura and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Belluscura's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Belluscura stock overvalued right now?
Belluscura (LSE:BELL) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Belluscura (LSE:BELL), the current OCF Yield % is 0.00 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Belluscura Business Description

Address 15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company has only one operating segment being the sale of oxygen concentrators in the United States. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.